These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 23354045)

  • 1. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
    Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
    Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
    Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
    Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene.
    Jahng JWS; Black KE; Liu L; Bae HR; Perez M; Ashley EA; Sallam K; Wu JC
    Stem Cell Res; 2021 May; 53():102284. PubMed ID: 33743362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
    Dalal D; Molin LH; Piccini J; Tichnell C; James C; Bomma C; Prakasa K; Towbin JA; Marcus FI; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    Circulation; 2006 Apr; 113(13):1641-9. PubMed ID: 16549640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Dalal D; James C; Devanagondi R; Tichnell C; Tucker A; Prakasa K; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    J Am Coll Cardiol; 2006 Oct; 48(7):1416-24. PubMed ID: 17010805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Qiu X; Liu W; Hu D; Zhu T; Li C; Li L; Guo C; Liu X; Wang L; Zheng H; Wang C; Diao Q; Shi D; Zhan P; Deng Y; Liu K; Wang Y; Liu B; Liu H; Zhang L
    Am J Cardiol; 2009 May; 103(10):1439-44. PubMed ID: 19427443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plakophilin-2 missense mutations in arrhythmogenic right ventricular cardiomyopathy.
    Lahtinen AM; Lehtonen A; Kaartinen M; Toivonen L; Swan H; Widén E; Lehtonen E; Lehto VP; Kontula K
    Int J Cardiol; 2008 May; 126(1):92-100. PubMed ID: 17521752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene.
    Khudiakov A; Kostina D; Zlotina A; Yany N; Sergushichev A; Pervunina T; Tomilin A; Kostareva A; Malashicheva A
    Stem Cell Res; 2017 Oct; 24():85-88. PubMed ID: 29034900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the Role of Wnt and Rho Signaling Pathway in iPSC-Derived ARVC Cardiomyocytes by In Silico Mathematical Modeling.
    Parrotta EI; Procopio A; Scalise S; Esposito C; Nicoletta G; Santamaria G; De Angelis MT; Dorn T; Moretti A; Laugwitz KL; Montefusco F; Cosentino C; Cuda G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular calcium current disorder and disease phenotype in
    Chen P; Xiao Y; Wang Y; Zheng Z; Chen L; Yang X; Li J; Wu W; Zhang S
    Theranostics; 2020; 10(24):11215-11229. PubMed ID: 33042279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Bourfiss M; Te Riele AS; Mast TP; Cramer MJ; VAN DER Heijden JF; VAN Veen TA; Loh P; Dooijes D; Hauer RN; Velthuis BK
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1420-1428. PubMed ID: 27572111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    den Haan AD; Tan BY; Zikusoka MN; Lladó LI; Jain R; Daly A; Tichnell C; James C; Amat-Alarcon N; Abraham T; Russell SD; Bluemke DA; Calkins H; Dalal D; Judge DP
    Circ Cardiovasc Genet; 2009 Oct; 2(5):428-35. PubMed ID: 20031617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal Recessive Nonsyndromic Arrhythmogenic Right Ventricular Cardiomyopathy without Cutaneous Involvements: A Novel Mutation.
    Soveizi M; Rabbani B; Rezaei Y; Saedi S; Najafi N; Maleki M; Mahdieh N
    Ann Hum Genet; 2017 Jul; 81(4):135-140. PubMed ID: 28523642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [THE EFFECT OF PLAKOPHILIN-2 GENE MUTATIONS ON ACTIVITY OF THE CANONICAL Wnt SIGNALING PATHWAY].
    Khudiakov AA; Kostina DA; Kostareva AA; Tomilin AN; Malashicheva AB
    Tsitologiia; 2015; 57(12):868-75. PubMed ID: 26995964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.
    Hariharan V; Asimaki A; Michaelson JE; Plovie E; MacRae CA; Saffitz JE; Huang H
    Cardiovasc Res; 2014 Nov; 104(2):280-9. PubMed ID: 25253076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV-Mediated Delivery of Plakophilin-2a Arrests Progression of Arrhythmogenic Right Ventricular Cardiomyopathy in Murine Hearts: Preclinical Evidence Supporting Gene Therapy in Humans.
    van Opbergen CJM; Narayanan B; Sacramento CB; Stiles KM; Mishra V; Frenk E; Ricks D; Chen G; Zhang M; Yarabe P; Schwartz J; Delmar M; Herzog CD; Cerrone M
    Circ Genom Precis Med; 2024 Feb; 17(1):e004305. PubMed ID: 38288614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of an arrhythmogenic right ventricular cardiomyopathy derived iPSC cell line (USFi004-A) carrying a heterozygous mutation in PKP2 (c.1799delA).
    Yang J; Samal E; Burgos Angulo M; Bertalovitz A; McDonald TV
    Stem Cell Res; 2021 Jul; 54():102398. PubMed ID: 34034221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique genetic background and outcome of non-Caucasian Japanese probands with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Wada Y; Ohno S; Aiba T; Horie M
    Mol Genet Genomic Med; 2017 Nov; 5(6):639-651. PubMed ID: 29178656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.